News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 08, 2018, 07:00 ET Endo Reports Third-Quarter 2018 Financial Results

Third-quarter 2018 revenues of $745 million compared to third-quarter 2017 revenues of $787 million Third-quarter 2018 XIAFLEX® franchise revenues increased 22 percent versus third-quarter 2017 to...


Nov 07, 2018, 07:30 ET Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc (NASDAQ: ENDP) announced positive results today from two identical Phase 3 RELEASE* studies of collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the...


Oct 11, 2018, 07:30 ET Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that data regarding the evaluation and rating of cellulite severity will be presented at the Annual Meeting of the American Society for...


Sep 28, 2018, 08:30 ET Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin® (methocarbamol tablets, USP) 750mg...


Sep 24, 2018, 06:00 ET Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to an additional stay of its litigation against the U.S. Food and Drug Administration (FDA) until December 31, 2018. The...


Sep 06, 2018, 11:02 ET Endo to Participate at Morgan Stanley Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Morgan Stanley 16th Annual Global Healthcare Conference in New York City on ...


Aug 15, 2018, 06:00 ET Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility

Endo International plc (NASDAQ: ENDP) today announced that it is lifting a temporary stay of its litigation against the U.S. Food and Drug Administration (FDA). The litigation, filed in the U.S....


Aug 09, 2018, 07:30 ET PGA Golfer Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Parents to Get Their Own Check-Ups This Back-to-School Season

Fresh off a successful summer of tournament play, four-time PGA TOUR winner Tim Herron is once again teaming up with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP),...


Aug 08, 2018, 07:00 ET Endo Reports Second-Quarter 2018 Financial Results

Second-quarter 2018 revenues of $715 million compared to second-quarter 2017 revenues of $876 million Second-quarter 2018 XIAFLEX® franchise revenues increased 27 percent versus second-quarter 2017...


Aug 02, 2018, 07:30 ET Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs

Endo International plc (NASDAQ: ENDP) announced today that it has appointed Laure Park as Senior Vice President, Investor Relations and Corporate Affairs, effective immediately. "I am excited to...


Jul 27, 2018, 07:30 ET Endo Begins Shipment of Authorized Generic Version of INVANZ® (ertapenem for injection) in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's INVANZ® (ertapenem for ...


Jul 25, 2018, 07:30 ET Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada

Endo International plc (NASDAQ: ENDP), announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with Bioprojet SCR to register, commercialize, and distribute...


Jul 20, 2018, 07:30 ET Endo to Announce Second-Quarter 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2018 financial results on August 8, 2018 and members of its senior management team will host a conference call and webcast...


Jul 02, 2018, 07:30 ET Endo Begins Shipment of Authorized Generic Version of Colcrys® (colchicine, USP) in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping an authorized generic version of Takeda Pharmaceutical's...


Jun 11, 2018, 15:20 ET Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC (collectively, "Endo" or the "Company") have executed a...


May 08, 2018, 06:30 ET Endo Reports First-Quarter 2018 Financial Results

First-quarter 2018 revenues of $701 million First-quarter 2018 Branded Specialty Products revenues increased 7 percent versus first-quarter 2017 to $112 million First-quarter 2018 XIAFLEX® franchise...


May 02, 2018, 07:30 ET Endo to Participate at the UBS Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Conference in New York City on Monday,...


Apr 27, 2018, 07:30 ET Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Featured During The Hot Topics Symposium At The Aesthetic Meeting 2018

Endo International plc (NASDAQ: ENDP) today announced the presentation of clinical data from a Phase 2b investigational study of collagenase clostridium histolyticum (CCH) for the treatment of...


Apr 26, 2018, 08:10 ET Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited

Endo International plc (NASDAQ: ENDP) today announced that it has reached definitive agreements to acquire Somerset Therapeutics, LLC, a New Jersey based specialty pharmaceutical company that...


Apr 23, 2018, 07:30 ET Paladin Labs Inc. Announces Launch of New Indication for XIAFLEX® (Collagenase Clostridium Histolyticum), Broadening Its Use to the Treatment of Appropriate Patients with Peyronie's Disease

Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) today announced the launch of a new indication for XIAFLEX® (collagenase clostridium histolyticum), the first and only Health...


Apr 19, 2018, 07:30 ET Paladin Labs Announces the Launch of Unisom® Snore Relief, the Only Natural Health Product Throat Spray Available in Canada to Help Relieve Symptoms Associated with Snoring

Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), announced today the launch of Unisom® Snore Relief, a new snore relief product from the makers of Unisom®, the trusted and...


Apr 17, 2018, 16:31 ET Endo Receives Paragraph IV Notification on Vasostrict®

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC, have received a Notice Letter dated April 16, 2018 (the "Notice...


Apr 13, 2018, 07:30 ET Endo to Announce First-Quarter 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2018 financial results on May 8, 2018 and members of its senior management team will host a conference call and webcast before...


Apr 02, 2018, 07:30 ET Endo Agrees to Extend Temporary Stay of FDA Litigation

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to extend a temporary stay of its litigation against the U.S. Food and Drug Administration (FDA). The litigation, filed in the ...


Mar 01, 2018, 18:30 ET Endo Obtains Preliminary Injunction Against QuVa Pharma, Inc. Preventing Marketing and Release of Vasopressin Product

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC (Par), have obtained a preliminary injunction preventing QuVa...